Jonas Brinck
Affiliated to Research | Docent
E-mail: jonas.brinck@ki.se
Visiting address: C2:94, Karolinska Universitetssjukhuset Huddinge, 14186 Stockholm
Postal address: H7 Medicin, Huddinge, H7 Endokrinologi och diabetes Parini, 171 77 Stockholm
Part of:
About me
- I started medical school at Uppsala university 1993 and completed my studies
in 2002. During this period, I was also a PhD student and defended my thesis
in 2000 at the of Department of Medical Biochemistry and Microbiology,
Uppsala university. I have worked clinically at Karolinska university
hospital since 2004 at the Medical unit Endocrinology in parallel to my
research at the Dept of Medicine Huddinge (MEDH7), KI. I have done a
post-doctorial fellowship at Geneva university hospital 2011-2015 in prof.
Richard W James group studying lipoprotein functionality in cellbased models.
I am today a senior consultant in endocrinology and diabetology. I am a
key-opinion-leader in the field of dyslipidaemia in Sweden and I am an
author/contributor to regional clinical guidelines.
Research
- My research focuses on epidemiological and experimental aspects of hereditary
dyslipidaemias. I am a team leader in the newly formed Cardiometabolic unit
at MEDH7 department under Professor Paolo Parini. In my research team is
KI-associated researcher Karin Littmann, PhD student Tigist Wodaje, research
nurse Viveca Åberg and medical student Simon Sjuls. We also perform clinical
trials in phase II-III in the field of dyslipidaemia and lipid lowering
therapy.
We study hereditary dyslipidaemias including Familial hypercholesterolemia,
elevated Lipoprotein(a) and Familial Chylomicronemia Syndrome and their
effects on atherosclerotic cardiovascular disease, metabolic disease, and
diabetes. In our clinical and experimental studies, we study their effects on
coronary blood flow capacity, endothel function and calcified aortic valve
disease biomarkers. In our epidemiological research, we are working with
regional and national cohorts to study their impact on various forms of
cardiovascular disease, development of cardiometabolic and liver disease.
Articles
- Article: CLINICAL SCIENCE. 2024;138(15):975-985
- Article: EUROPEAN HEART JOURNAL OPEN. 2024;4(2):oeae010
- Article: JOURNAL OF COLLOID AND INTERFACE SCIENCE. 2023;645:627-638
- Article: JOURNAL OF INTERNAL MEDICINE. 2023;293(2):228-245
- Article: DIABETES CARE. 2022;45(12):3040-3049
- Article: AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. 2022;323(5):H1004-H1009
- Article: ATHEROSCLEROSIS. 2022;349:175-182
- Article: LAKARTIDNINGEN. 2022;119:21210
- Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2022;28(18):2038-2047
- Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2021;78(4):551-559
- Article: ATHEROSCLEROSIS. 2021;316:48-52
- Article: DIABETES CARE. 2020;43(8):1851-1858
- Article: EUROPEAN HEART JOURNAL: CASE REPORTS. 2020;4(1):1-6
- Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2018;48(2)
- Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2017;47(1):38-43
- Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2016;36(5):817-824
- Article: JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. 2015;16(2):328-338
- Article: PLOS ONE. 2015;10(3):e0119664
- Article: JOURNAL OF BONE AND MINERAL METABOLISM. 2012;30(2):202-207
- Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2009;88(3):308-313
- Article: CLINICAL RHEUMATOLOGY. 2008;27(8):1035-1038
- Article: OSTEOPOROSIS INTERNATIONAL. 2008;19(2):177-183
- Article: BIOCHEMICAL JOURNAL. 2000;348 Pt 1(Pt 1):29-35
- Article: EXPERIMENTAL CELL RESEARCH. 1999;252(2):342-351
- Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 1998;1380(3):377-388
- Show more
All other publications
- Editorial comment: ANNALS OF MEDICINE. 2022;54(1):1952-1955
- Other: EUROPEAN HEART JOURNAL: CASE REPORTS. 2021;5(5):ytab151
- Review: LAKARTIDNINGEN. 2019;116:FLMW
Employments
- Affiliated to Research, Department of Medicine, Huddinge, Karolinska Institutet, 2023-2024
Degrees and Education
- Docent, Karolinska Institutet, 2021